- Home
- EBON vs GNTA Comparison
EBON vs GNTA Comparison
Compare EBON & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EBON | GNTA |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | China | Italy |
| Employees | N/A | 13 |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5M | 19.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBON | GNTA |
|---|---|---|
| Price | $2.33 | $0.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.2K | ★ 60.6K |
| Earning Date | 04-27-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $0.61 |
| 52 Week High | $5.90 | $10.00 |
Technical Indicators
Market Signals| Indicator | EBON | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 42.36 | 25.64 |
| Support Level | $2.31 | N/A |
| Resistance Level | $2.94 | $1.70 |
| Average True Range (ATR) | 0.19 | 0.08 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 3.70 | 8.95 |
Price Performance
Historical ComparisonAbout EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.